Trial Profile
A direct comparison of Oral Navelbine given either classic or metronomic in metastatic breast cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Sep 2023
Price :
$35
*
At a glance
- Drugs Vinorelbine (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms The NaMe trial
- 10 Apr 2023 Status changed from recruiting to completed.
- 13 Jan 2023 This trial has been completed in Denmark, according to European Clinical Trials Database record.
- 18 Jul 2017 New trial record